NYSE: CLColgate Palmolive Co Stock
$92.03+2.44 (+2.72%)
Updated Mar 26, 2025
CL Price
$92.03
Fair Value Price
N/A
Market Cap
$74.69B
52 Week Low
$85.32
52 Week High
$109.30
P/E
26.07x
P/B
352.29x
P/S
3.7x
PEG
3.98x
Dividend Yield
1.63%
Revenue
$20.10B
Earnings
$2.89B
Gross Margin
60.5%
Operating Margin
20.34%
Profit Margin
14.4%
Debt to Equity
73.12
Operating Cash Flow
$4B
Beta
0.34
Next Earnings
Apr 24, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CL Overview
Colgate-Palmolive Company offers a wide range of household, health care, and personal care products. Its home care products includes Ajax, Axion, and Palmolive dishwashing liquids and Ajax, Fabuloso, and Murphy household cleaners. The company also owns specialty pet food maker, Hill's, which sells its products through veterinarians and specialty pet retailers. Colgate-Palmolive was founded in 1806 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CL's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
C
CL
Ranked#17 of 25
Ranked#17 of 25
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $6.93 | B | |
| $58.19 | B | |
| $33.36 | B |
Be the first to know about important CL news, forecast changes, insider trades & much more!
CL News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CL ($92.03) is trading above its intrinsic value of $27.47, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CL is good value based on its earnings relative to its share price (26.07x), compared to the US market average (31.65x)
P/E vs Market Valuation
CL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CL due diligence checks available for Premium users.
Valuation
CL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
26.07x
Industry
25.12x
Market
31.65x
CL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
352.29x
Industry
7.45x
CL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CL price to earnings growth (PEG)
For valuing profitable companies with growth potential
CL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CL's financial health
Profit margin
Revenue
$4.9B
Net Income
$739.0M
Profit Margin
14.9%
CL's Earnings (EBIT) of $4.09B... subscribe to Premium to read more.
Interest Coverage Financials
CL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$16.0B
Liabilities
$15.5B
Debt to equity
73.12
CL's short-term liabilities ($5.76B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CL's long-term liabilities ($9.74B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.3B
Investing
-$80.0M
Financing
-$1.3B
CL's operating cash flow ($4.11B)... subscribe to Premium to read more.
Debt Coverage Financials
CL vs Household & Personal Product Stocks
Colgate Palmolive Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.